- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 277/34 - Atomes d'oxygène
Détention brevets de la classe C07D 277/34
Brevets de cette classe: 233
Historique des publications depuis 10 ans
|
14
|
19
|
11
|
23
|
5
|
13
|
12
|
8
|
12
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cirius Therapeutics, Inc. | 33 |
9 |
| The Board of Regents of the University of Texas System | 2294 |
7 |
| Cv6 Therapeutics (NI) Limited | 33 |
7 |
| Poxel SA | 22 |
6 |
| Metabolic Solutions Development Company, LLC | 23 |
5 |
| Shionogi & Co., Ltd. | 873 |
5 |
| Immunesensor Therapeutics, Inc. | 36 |
5 |
| Bayer Pharma AG | 1014 |
4 |
| The Regents of the University of California | 20720 |
3 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| Syngenta Participations AG | 1527 |
3 |
| Syngenta Crop Protection AG | 6699 |
3 |
| Sumitomo Chemical Company, Limited | 8996 |
3 |
| University of Southern California | 2128 |
3 |
| CalciMedica, Inc. | 92 |
3 |
| Industry-Academic Cooperation Foundation, Chosun University | 317 |
3 |
| Pusan National University Industry-University Cooperation Foundation | 748 |
3 |
| Merck Sharp & Dohme LLC | 3735 |
3 |
| LG Chem, Ltd. | 17921 |
2 |
| The Johns Hopkins University | 5875 |
2 |
| Autres propriétaires | 151 |